Dr Najia Ghanchi's research interest includes diagnostics, antimalarial drug resistance, P. vivax epidemiology, clinical drug trials with additional interest in emerging infections and Pathogen genomics.

Currently, Dr Najia is conducting studies to evaluate radical cure strategies for Plasmodium vivax, drug resistance in malaria parasites, and evaluating new diagnostic assays. Her current projects are evaluating rapid diagnostic tests for malaria case detection as well as diagnostic tests that enable safe radical cure of P. vivax malaria such as point-of-care tests for glucose-6-phosphate dehydrogenase (G6PD) deficiency.

She has an extensive expertise in molecular biology, focusing on the identification and understanding of the genetic characteristics of pathogens and integrating this knowledge into clinical diagnostics.